News

Built on MVE’s legacy SC 4/2V and 4/3V vapor shipper platform, the next-generation SC 4/2V and 4/3V models have been ...
Celltrion USA announced that Stoboclo (denosumab-bmwo) and Osenvelt (denosumab-bmwo), biosimilars referencing Prolia ...
Centauri Therapeutics Limited, an immunotherapy company, has appointed Dr. Debra Barker as Chief Medical Officer (CMO).
Dr. Richard Philipson has been appointed Chief Medical Officer (CMO) of Hansa Biopharma AB, effective July 14.
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Fujifilm’s FF-10832, an investigational liposomal formulation of gemcitabine, for the treatment of biliary tract ...
Natoli Engineering's Precision CT Scan allows manufacturers to visualize internal tablet structures without cutting or ...
Almac Clinical Services has completed a multi-million-dollar investment to enhance cold chain capabilities at its global ...
Biosynth, a developer and supplier of critical raw materials and services for life sciences and diagnostics, has opened an expanded GMP bioconjugation facility at its existing Berlin site.
Körber’s Business Area Pharma now offers a standardized approach to connect systems and equipment to its market-leading PAS-X ...
The CDMO has increased its capacity by acquiring and installing a new, fully Annex 1 compliant, sterile filling line. As a ...
Axplora has announced a transformative €35 million ($41.2 million) expansion at its Farmabios site in Gropello Cairoli, Italy ...
Pace Life Sciences LLC is remodeling and expanding its Salem, NH, site to establish a Center of Excellence for Aseptic ...